1-4 of 4
Xiao Yu
Close
Sort by
Journal Articles

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Jun Shi, Riguo Fang, Zhen Gao, Zhongyu Shi, Zhexiang Kuang, Yongjian Zhang, Lele Zhang, Huihui Yang, Yingchi Zhang, Dehui Zou, Liwei Fang, Jiali Sun, Qiang Li, Yao Zou, Hong Pan, Jingyu Zhao, Liyun Li, Xiao Yu, Jing Xu, Chun Xu, Yanjie Liu, Weiwei Wang, Jia Shi, Jie Liu, Jia Wang, Nian Shi, Lei Yang, Weiqiang Wang, Suyi Li, Moye Shi, Xiaoshuang Zhang, Pengfei Yuan, Wensheng Wei, Dong Wei, Tao Cheng
Journal: Blood
Blood (2022) 140 (Supplement 1): 10652–10653.
https://doi.org/10.1182/blood-2022-166365
Published: 2022
Journal Articles

The Expression and Mechanism of Tim3 and PD-1 in Patients with Acute Myeloid Leukemia

Caixia Li, PhD, Xiao Yu, Caihong Gu, Chao Ma, Hong Liu, Wang Tong, Qiu Zou, Lu Ye, Xiaochen Chen, Wu Depei, MD
Journal: Blood
Blood (2015) 126 (23): 4948.
https://doi.org/10.1182/blood.V126.23.4948.4948
Published: 2015
Journal Articles

TIM-3 Is Highly Expressed On Blast Cells In Patients With Acute Myeloid Leukemia

Caixia Li, Xiao Yu, Yibei Zhu, Xiaojin Wu, Xiao Ma, Hong Liu, Lu Ye, Chao Ma, Rui Xia, Aining Sun, Changgeng Ruan, MD, PhD, Suning Chen, Wu Depei
Journal: Blood
Blood (2013) 122 (21): 4931.
https://doi.org/10.1182/blood.V122.21.4931.4931
Published: 2013
Journal Articles

The Regulation of Telomere Binding Proteins on Telomerase during Differentiation of ATRA Responsive and Resistant NB4 Cells.

He Huang, Ph.D, Jie Sun, Ph.D, Yuan Yuan Zhu, M.D., Jian Ping Lan, M.D., Xiao Yu Lai, M.D.
Journal: Blood
Blood (2004) 104 (11): 3390.
https://doi.org/10.1182/blood.V104.11.3390.3390
Published: 2004